Umoja Biopharma Appoints Scott Myers as Chairman of its Board of Directors


SEATTLE, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Umoja Biopharma, Inc. (Umoja), the clinical-stage leader of in vivo and off-the-shelf therapies that aim to realize the full reach and promise of CAR T-cells, today announced that Scott Myers has been appointed as Chairman of its Board of Directors, succeeding Dieter Weinand who will remain as an advisor.

More here:
Umoja Biopharma Appoints Scott Myers as Chairman of its Board of Directors

Related Posts